Vanda Pharmaceuticals to Present Data on Fanapt(TM) and Tasimelteon at the 162nd American Psychiatric Association Annual Meeting
... of circadian rhythm sleep disorders, including
transient insomnia caused by jet lag.
The following ... on Sleep
Architecture in Phase Advanced
transient Insomnia.
NR7-100 Effect of Melatonin ... and Architecture in a Phase Advance Model of
transient Insomnia.
About Vanda
Vanda ...
Fraunhofer USA Center for Molecular Biotechnology Receives Gates Foundation Grant for Avian Influenza Vaccine Development
... to support continued development of an avian influenza vaccine that
uses
transient plant-based technology. CMB will develop vaccines against
highly ... it as a
platform for accelerated manufacturing pharmaceuticals. The
transient plant-
based expression technology is licensed by CMB from its partner, ...
Dry Eye Survey: Ophthalmologists Cite Treatment Limitations/Gaps in Treatment of Moderate to Severe Dry Eye
... .
Most adverse reactions with Lacrisert were mild and
transient and
included
transient blurring of vision, ocular discomfort or irritation,
matting or stickiness ...
Savient's Pegloticase Data in Treatment-Failure Gout Patients Presented at 72nd Annual Meeting of the American College of Rheumatology Conference
... similar to placebo indicating that the early increase in flares was
transient in this treatment arm before returning to the placebo level.
The ... 1, GOUT 2, and GOUT 3) identified two adverse safety signals: the
transient increase in gout flares in Months 1-3 and the occurrence of infusion ...
A snapshot of the transformation
... DTEM comes in. It provides scientists with the ability to image
transient behavior with an unprecedented combination of spatial and temporal ... to binary alloy solidification," Kim said. "This conclusion is based upon
transient features that could not have been found using any other technique."
...
Aton Pharma Introduces Expanded Distribution of Lacrisert(R) (hydroxypropyl cellulose ophthalmic insert) at Hawaiian Eye
... with dry eye states.
Most adverse reactions with Lacrisert were mild and
transient and
included
transient blurring of vision, ocular discomfort or irritation,
matting or stickiness ...
Medicago's H1N1 pandemic vaccine candidate shows positive response in 100% of vaccinated animals after a single dose
... Virus-Like Particle (VLP) and manufacturing technologies. Medicago is developing VLP vaccines to protect against H5N1 pandemic influenza, using a
transient expression system which produces recombinant vaccine antigens in non-transgenic plants. This technology has potential to offer advantages of speed ...
Amylin Pharmaceuticals Announces Positive Results from Dose-Ranging Clinical Study of Pramlintide/Metreleptin Combination Treatment for Obesity
... effects seen with pramlintide/metreleptin combination treatment were injection site adverse events and nausea, which were mostly mild or moderate and
transient in nature.
"These findings provide us with valuable data that will inform our clinical and product development strategy moving forward," said ...
Biovista Inc. Announces Positive Efficacy Results in a Pre-Clinical Trial of its BVA-601 Repositioned Drug for Epilepsy
... model of epilepsy
Epilepsy is a common chronic neurological disorder characterized by
recurrent unprovoked seizures. These seizures may be
transient signs and/or
symptoms due to abnormal, excessive or synchronous neuronal activity in the
brain. Epilepsy is one of the world's oldest recognized ...
Intarcia Therapeutics, Inc. Presents ITCA 650 Phase 1b Study Results as a Late-Breaker at the American Diabetes Association 69th Scientific Sessions
... HbA1c and body weight were observed across all dose arms. The most commonly reported adverse events were nausea and vomiting which were mostly mild,
transient and dose dependent.
"The results from the ITCA 650 phase 1b study have provided important guidance toward dose selection and study design for ...
Medicago succesfully expresses VLP antigen for A H1N1 strain
... Virus-Like Particle (VLP) and manufacturing technologies. Medicago is developing VLP vaccines to protect against H5N1 pandemic influenza, using a
transient expression system which produces recombinant vaccine antigens in non-transgenic plants. This technology has potential to offer advantages of speed ...
Exenatide Once Weekly New Drug Application Submitted to FDA for Type 2 Diabetes
... associated with an average weight loss of 8 pounds from baseline. The most commonly reported adverse event was nausea, which was typically mild and
transient and occurred less frequently in the exenatide once weekly patients. In addition, a meta-analysis across controlled clinical studies of three months ...
NeurogesX Presents Two Posters at 61st Annual American Academy of Neurology Annual Meeting
... show no detrimental neurologic effects of repeated treatment with Qutenza. The most common adverse reactions observed in these clinical trials were
transient application site reactions (pain and/or erythema) that were mostly mild to moderate in intensity.
NeurogesX submitted a new drug application ...
Medicago initiates work on Swine Flu strain
... Virus-Like Particle (VLP) and manufacturing technologies. Medicago is developing VLP vaccines to protect against H5N1 pandemic influenza, using a
transient expression system which produces recombinant vaccine antigens in non-transgenic plants. This technology has potential to offer advantages of speed ...
Researchers develop new way to see single RNA molecules inside living cells
... dynamic RNA-protein co-localization, which is the joining of RNA molecules and RNA binding proteins in a single cell.
"We observed substantial
transient interactions between proteins and viral RNA molecules that I don't think had ever been seen before with non-engineered RNA," noted Santangelo. "We ...
Bionovo Announces Publication of Positive Phase 2 Trial Results for Menerba(TM)
... with 98% of participants completing
the trial and 91% taking at least 75% of assigned doses. The only
statistically significant side effect was
transient loose stools (12% on
Menerba versus 3% on placebo; p=0.03).
Safety analyses showed no cases of endometrial hyperplasia or uterine
cancer ...
European Commission Approves EFIENT(R) (prasugrel) for Patients with Acute Coronary Syndrome Undergoing PCI
... readily identifiable: patients who weighed less than 60 kg (132 lbs), patients who were 75 years of age or older and patients who have had a prior
transient ischemic attack (TIA) or stroke. Patients who weighed less than 60 kg, or were 75 years of age or older had increased exposure with prasugrel.
...
Promising Clinical Data on Gen-Probe's APTIMA(R) HPV Test Presented at Major European Medical Meeting
... for the development of cervical cancer. While most
women will be infected with HPV at some point in their lives, the majority of
these infections are
transient and resolve without any clinical symptoms or
consequences. However, a small number of HPV infections progress and result in
disease ranging from ...
deCODE Study Expands Clinical Utility of deCODE AF(TM) for Improving the Diagnosis of Atrial Fibrillation and Preventing Stroke
... under diagnosed. Detecting
AF frequently requires more extensive cardiac monitoring than is feasible
on all patients who have suffered stroke or
transient ischemic attack
(TIA).
deCODE's newly presented data demonstrate that the SNPs measured by
deCODE AF(TM) are the most significant known genetic ...
Dry adhesive based on carbon nanotubes gets stronger, with directional gripping ability
... University of Dayton. "This directional difference in the adhesion force is a significant improvement that could help make this material useful as a
transient adhesive."
The key to the new material is the use of rationally-designed multi-walled carbon nanotubes formed into arrays with "curly entangled ...
Nomad Bioscience Announces Broad License Agreement
... agreement with Bayer
Innovation GmbH and Icon Genetics group. It provides Nomad access to Icon's
proprietary technology platforms, including its
transient expression
technology magnICON(R), for manufacturing biomaterials and selected
biosimilar pharmaceutical proteins in green plants. The agreement ...
InterMune to Present Four Abstracts on HCV Protease Inhibitor ITMN-191 at the AASLD Meeting
... safe and well tolerated when given as a single
dose to healthy adults in a range of doses from 2mg to 1600mg. Adverse
events were generally mild and
transient and were similar between treatment
groups, with the exception of a higher frequency of mild and transient
diarrhea and abdominal pain in the ITMN-191 ...
Cardica Receives $1 Million Milestone Payment From Cook Medical for Development of Heart Defect Closure Device
... minimally invasive alternative to current treatments to permanently
close the hole in the heart. This may potentially reduce the risk of
stroke,
transient ischemic attack and debilitating migraines."
In June 2007, Cardica and Cook entered into an agreement to develop a
PFO closure device, whereby ...
Braemar Introduces the ER920W Wireless Cardiac Arrhythmia Monitor
... monitoring products
currently under development."
Cardiac arrhythmia monitors are worn by patients for up to 30 days to
document and record
transient cardiac events. Recording of symptomatic
events such as syncope, palpitations, dizziness, chest discomfort and
shortness of breath is activated by ...
Cardium Launches New AWARE Clinical Study Website
... ischemic stress (insufficient blood flow and myocardial oxygen
supply due to coronary heart disease). The natural biologic response to
repeated
transient ischemia is angiogenesis, the growth of new collateral
blood vessels, which is orchestrated by a complex and incompletely
understood cascade ...
Gen-Probe Launches in Europe CE-Marked APTIMA(R) HPV Assay for Detection of Human Papillomavirus
... for the development of cervical cancer. While
most women will be infected with HPV at some point in their lives, the
majority of these infections are
transient and resolve without any clinical
symptoms or consequences. However, a small number of HPV infections
progress and result in disease ranging from ...
Nebulized Formoterol Fumarate Has Comparable Pharmacokinetic and Pharmacodynamic Profile to Dry Powder Formulation
... and DPI," showed
comparability in linear kinetics and excreted drug levels between
formoterol fumarate administered by nebulization and DPI.
transient and
dose-related effects on serum potassium, serum glucose and vital signs were
observed and found to be comparable between the two formulations.
...
FDA Approves MIXJECT(TM), a Convenient, Easy-to-Use Drug Delivery System For Watson Pharmaceutical's TRELSTAR(R) DEPOT and TRELSTAR(R) LA
... events occurring in
patients were hot flushes, skeletal pain, impotence and headache. As with
all LHRH agonists, triptorelin causes an initial
transient increase in
testosterone levels and may initiate or worsen symptoms during this
transient period. Rare post-marketing reports of anaphylactic shock ...
Cephalon Announces European Commission Approval of EFFENTORA for the Treatment of Breakthrough Cancer Pain
... In patients with cancer, chronic pain often has two components:
persistent pain and breakthrough cancer pain. Breakthrough pain is an
intense
transient flare of pain that interrupts or "breaks through" their
persistent pain. The onset of breakthrough cancer pain is often sudden,
reaches peak ...
ABR-Affinity BioReagents Finalizes Agreement for Distribution of Osenses Antibodies in the U.S., Canada and Europe
... antibodies for experimental use in the areas of
chemosensory receptors (olfactory, vomeronasal and trace amine-associated),
and visual, auditory and
transient receptors. According to Ken Wilczek,
President of ABR-Affinity BioReagents, "Partnering with Osenses enhances
our ability to offer experimental ...
Stereotaxis Reports Fourth Quarter and Full Year 2007 Financial Results
... that a 94% acute success rate was achieved in these cases, with
a high satisfaction rating by clinicians, and that there was only one minor
and
transient adverse event. We are proud of this exemplary safety record.
In addition, the average economics per case from disposable revenue at
these sites to ...
BSP's New Line of HyperQ Products: Bedside Ischemia Monitoring Systems Announces Successful Results of First Feasibility Study
... on sophisticated analysis of high-frequency ECG
components, can be implemented in two products: (i) bedside monitoring
system for early detection of
transient ischemic episodes and (ii) a
resting ECG system for sensitive diagnosis of acute coronary syndrome,
including myocardial infarction. A highly ...
Clontech Laboratories, Inc. Releases the ProteoTuner(TM) Systems
... systems have broad applications in basic and
applied research. The fast kinetics of protein
stabilization/destabilization make it possible to study
transient effects
of the protein of interest that might otherwise have been masked. The
ability to directly control the level of functional protein also makes ...
Cephalon's EFFENTORA Receives Positive Opinion from European Regulatory Authorities for the Management of Breakthrough Cancer Pain
... pain, a transitory exacerbation of pain
that occurs on a background of otherwise controlled persistent chronic
pain. Patients experience intense
transient flares of pain that interrupt,
or "break through," their background persistent pain. Breakthrough pain is
characterized by its rapid onset, ...
U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) as the First Medication for Add-On Treatment of Major Depressive Disorder (MDD)
... dose changes. ABILIFY is not approved for use in
pediatric patients with depression (See Boxed WARNING). Cerebrovascular adverse events (eg, stroke,
transient ischemic attack), including fatalities, have been reported at an increased incidence in clinical trials of elderly patients with dementia-related ...
Presentation of Phase IIa Results for Cytos Biotechnology's Hypertension Vaccine at the American Heart Association Scientific Sessions 2007
... blood pressure monitoring. Both dose levels of CYT006-AngQb tested were safe and well tolerated.
The majority of side effects observed were
transient and mostly mild local
injection site reactions. During the entire safety follow-up period from
month 4 to 12 after the first injection, no ...
New force-fluorescence device measures motion previously undetectable
... to pulling forces in three different directions, the researchers mapped the location of the transition states and deduced the structure of the
transient species present during the conformational changes.
Based on our previous studies, we knew the Holliday junction fluctuated between two structures, ...
Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
... as described below in the FENTORA label, for their
underlying persistent cancer pain. FENTORA incorporates a drug delivery
system that generates
transient changes in pH, which may optimize how well
the tablet dissolves and how quickly the medicine passes across the lining
of the cheek, or buccal mucosa. ...
HTRF IP-One Assay Performed on the PHERAstar and RUBYstar Plate Readers
...
of Gq coupled GPCRs result in a
transient increase of intracellular Ca 2+
... its detection highly inaccurate. IP3 induces a
transient calcium release
in the cell. Calcium ... cellular
backgrounds, stable or
transient transfected cells, and chimeric constructs.
...